Skip to content

Clinical trials

Phase 2 Lung Diseases trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Phase 2 Country / region: Italy Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20091
20151
20162
20212
20231
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting4
Active, not recruiting2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
Upstream Bio Inc.2
Bayer1
Debiopharm International SA1
Eli Lilly and Company1
Iovance Biotherapeutics, Inc.1
NovaBiotics Ltd.1
OncoMed Pharmaceuticals, Inc.1
Pulmovant, Inc.1
Revolution Medicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases14
Respiratory Tract Diseases6
Carcinoma5
Lung Neoplasms5
Asthma3
Carcinoma, Non-Small-Cell Lung3
Bronchial Diseases2
Bronchial Neoplasms2
Cardiovascular Diseases2
Fibrosis2

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.